Cargando…

X-box Binding Protein 1 is a Potential Immunotherapy Target in Ovarian Cancer

The allure of potentially dramatic and durable responses to immunotherapy has driven the study of several immune checkpoint inhibitor (ICI) agents in ovarian cancer. However, the results of ICI therapy in ovarian cancer have been rather disappointing. It is important to understand the reasons for th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yanhui, Yang, Lewei, Jiang, Ling, Yu, Wenyan, Jin, Zhongwen, Qiu, Yeqing, Liao, Yifeng, Liu, Jihong, Zhang, Hongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386150/ https://www.ncbi.nlm.nih.gov/pubmed/35991556 http://dx.doi.org/10.3389/fgene.2022.818917

Ejemplares similares

Regulation of Nrf2 by X Box-Binding Protein 1 in Retinal Pigment Epithelium
por: Chen, Chen, et al.
Publicado: (2018)

Evaluation of Splicing on X-box Binding Protein Transcript in Tissue Samples of Colorectal Cancer
por: Ahmadi, Azam, et al.
Publicado: (2019)

Ovarian Carcinosarcoma and Response to Immunotherapy
por: Daniyal, Muhammad, et al.
Publicado: (2023)

Glycosylated Cathepsin V Serves as a Prognostic Marker in Lung Cancer
por: Yang, Lewei, et al.
Publicado: (2022)

Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022)

Integrated Analysis of the Prognosis-Associated RNA-Binding Protein Genes and Candidate Drugs in Renal Papillary Cell Carcinoma
por: Jiang, Silin, et al.
Publicado: (2021)

Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment
por: Zhou, Jiao, et al.
Publicado: (2023)

The MADS-box transcription factor PHERES1 controls imprinting in the endosperm by binding to domesticated transposons
por: Batista, Rita A, et al.
Publicado: (2019)

X-box binding protein 1: A new metabolic mediator and drug target of metformin?
por: Lou, Kai, et al.
Publicado: (2022)

Development and Validation of Genome Instability-Associated lncRNAs to Predict Prognosis and Immunotherapy of Patients With Hepatocellular Carcinoma
por: Yan, Yifeng, et al.
Publicado: (2022)

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit
por: Hou, Yue, et al.
Publicado: (2023)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

HMG-boxes, ribosomopathies and neurodegenerative disease
por: Moss, Tom, et al.
Publicado: (2023)

Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
por: Guo, Yangyang, et al.
Publicado: (2023)

Integrated Analysis of Prognostic and Immune Associated Integrin Family in Ovarian Cancer
por: Wu, Anqi, et al.
Publicado: (2020)

Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis
por: Zhao, Yaqi, et al.
Publicado: (2022)

Corrigendum: Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
por: Guo, Yangyang, et al.
Publicado: (2023)

Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review
por: Fink, Dorothy A., et al.
Publicado: (2018)

Precision Medicine Needs to Think Outside the Box
por: Martschenko, Daphne O., et al.
Publicado: (2022)

Preimplantation Genetic Testing for a Chinese Family With X-Linked Lymphoproliferative Syndrome Type 1
por: Chen, Songchang, et al.
Publicado: (2020)

RNA-Binding Protein IGF2BP1 Associated With Prognosis and Immunotherapy Response in Lung Adenocarcinoma
por: Liu, JinFeng, et al.
Publicado: (2022)

Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response
por: Li, Xiang, et al.
Publicado: (2022)

Computable structured aptamer for targeted treatment of ovarian cancer
por: Ruan, Luoshan, et al.
Publicado: (2023)

Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma
por: He, Yunan, et al.
Publicado: (2020)

Identification of a novel reactive oxygen species (ROS)-related genes model combined with RT-qPCR experiments for prognosis and immunotherapy in gastric cancer
por: Cen, Kenan, et al.
Publicado: (2023)

Nobiletin Induces Ferroptosis in Human Skin Melanoma Cells Through the GSK3β-Mediated Keap1/Nrf2/HO-1 Signalling Pathway
por: Feng, Senling, et al.
Publicado: (2022)

Characteristics of the Immune Cell Infiltration Landscape in Gastric Cancer to Assistant Immunotherapy
por: Li, Chenlu, et al.
Publicado: (2022)

Health and reproductive experiences of women with an FMR1 premutation with and without fragile X premature ovarian insufficiency
por: Wheeler, Anne C., et al.
Publicado: (2014)

The Pandora’s box of transparency opened by direct-to-consumer genetic testing
por: Saruwatari Zavala, Garbiñe
Publicado: (2023)

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Identification and Validation of an Immune Evasion Molecular Subgroup of Patients With Colon Cancer for Implications of Immunotherapy
por: Zhang, Hongbin, et al.
Publicado: (2022)

Molecular Characterization and Clinical Relevance of RNA Binding Proteins in Colorectal Cancer
por: Zhang, Zhen, et al.
Publicado: (2020)

An immune and epithelial–mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas
por: Luo, Wei, et al.
Publicado: (2023)

MADS-Box Gene Classification in Angiosperms by Clustering and Machine Learning Approaches
por: Chen, Yu-Ting, et al.
Publicado: (2019)

The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer
por: Jiang, Xuefei, et al.
Publicado: (2022)

Case Report: Whole Exome Sequencing Revealed Two Novel Mutations of PIEZO1 Implicated in Nonimmune Hydrops Fetalis
por: Chen, Yuan, et al.
Publicado: (2021)

ML323 suppresses the progression of ovarian cancer via regulating USP1-mediated cell cycle
por: Song, Baozhi, et al.
Publicado: (2022)

Immunotherapy Resistance in Glioblastoma
por: Wang, Elaina J., et al.
Publicado: (2021)

Lactate score predicts survival, immune cell infiltration and response to immunotherapy in breast cancer
por: Yin, Ting-Ting, et al.
Publicado: (2022)

Identification of the Functions and Prognostic Values of RNA Binding Proteins in Bladder Cancer
por: Wu, Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pne4gtrt5p283b5i5p0k9f1svk